FINWIRES · TerminalLIVE
FINWIRES

Columbus McKinnon Reprices $1.45 Billion Term Loan, $500 Million Revolving Facility

By

Columbus McKinnon (CMCO) said Tuesday it completed a repricing of its $1.45 billion Term Loan B due Feb. 3, 2033, and $500 million revolving credit facility.

The amendment reduced the interest rate margin on both facilities by 50 basis points, bringing the Term Loan B rate to SOFR plus 3.00% per annum.

The company said all other material terms, including the maturity dates, remain unchanged.

Shares of Columbus McKinnon were up 5.9% in early Tuesday trading.

Price: $16.44, Change: $+0.91, Percent Change: +5.86%

What else is happening in Wire?

Wire

Inghams Group Says Mitsubishi UFJ Financial's Stake in Firm Falls

Inghams Group (ASX:ING) said Mitsubishi UFJ Financial Group's voting power in the firm fell to 6.19% from 7.2% as of Sept. 16, according to a Tuesday Australian bourse filing.The Japanese bank holds nearly 23 million ordinary shares of the firm as of Sept. 16.Inghams Group's shares fell past 1% in recent trading on Tuesday.

ASX:ING
Wire

AnaptysBio Swings to Q2 Profit as Revenue Rises; Shares Gain After Hours

AnaptysBio (ANAB) reported Q2 net income late Monday of $5.11 per diluted share, swinging from the loss of $1.30 a year earlier.Revenue in the three months ended June 30 rose to $27.5 million from $22.3 million a year earlier.The company's shares rose 4.5% in after-hours trading.

$ANAB
Wire

Moderna Provides Details on Data Presentations at Upcoming Conferences

Moderna (MRNA) said Monday that phase 3 data for intismeran autogene in resected stage IIB-IV melanoma will be presented at a Presidential Symposium during the ESMO Congress 2026 on Oct. 24.The company said three abstracts on the investigational individualized neoantigen therapy were accepted for presentation, including data from a phase 1 pancreatic cancer study and a phase 3 lung cancer study.The company will also present in the Bernstein Insights Healthcare Leaders and Disruptors - 3rd Annual Healthcare Forum on Sept. 23, according to its website.Price: $173.39, Change: $+19.35, Percent Change: +12.56%

$MRNA